NCT06240169

Brief Summary

Study Title: - Effect of age on the success of direct pulp capping using bio-ceramic materials in cariously exposed teeth with reversible pulpitis: A Prospective clinical study. Rationale: - Preservation of pulp vitality is a critical factor in long-term tooth survival. In deep carious lesion with reversible pulpitis, vital pulp therapy procedures in the form of direct pulp capping(DPC)is more conservative treatment strategy, based on the premise that a biologically active material placed in direct contact with the pulp wound can determine the pulpal response and result in the development of a reparative hard tissue bridge to preserve pulp vitality. Patient's age may have a role in the survival rate after direct pulp capping and the role of the pulp capping material has been recognized as an important parameter for the success of treatment. Research Question : Does age has any influence on the success of DPC procedure and is there any difference between MTA and Biodentine as DPC material in cariously exposed permanent teeth with reversible pulpitis? Aim \& Objectives- To evaluate the effect of age on success of Direct Pulp Capping, to evaluate the success of MTA and Biodentine as direct pulp capping agents.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
174

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 2, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

February 2, 2024

Status Verified

January 1, 2024

Enrollment Period

10 months

First QC Date

January 14, 2024

Last Update Submit

January 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • clinical and radiographic success rates and evaluation of the effect of age on the success of procedure.

    CLINICAL SUCCESS CRITERIA * Absence of sign and symptoms of pain on stimulus or spontaneous pain. * Absence of tenderness to palpation or percussion and presence of functional tooth. * Absence of any soft tissue swelling sinus or fistula. * Normal tooth mobility and no periodontal probing depth. * Positive response to pulp sensibility test (cold and EPT). RADIOGRAPHIC SUCCESS CRITERIA * Periapical Index (PAI) score ≤2. * Absence of external or internal root resorption. Also, to evaluate the effect of age on the success of procedure.

    Baseline to 18 months

Secondary Outcomes (1)

  • Post operative pain Secondary outcome measure will be pain intensity after treatment. Secondary outcome measure will be pain intensity after treatment. Secondary outcome measure will be pain intensity after treatment.

    Base line to 7 days

Study Arms (4)

DPC in AGE I with MTA

EXPERIMENTAL

DPC using MTA in Age group I i.e. 18-40years.

Procedure: DPC with MTA in AGEI

DPC in AGE I with BD

EXPERIMENTAL

DPC using BD in Age group I i.e. 18-40years.

Procedure: DPC with BD in AGEI

DPC in AGE II with MTA

EXPERIMENTAL

DPC using MTA in Age group II i.e. 41-60years

Procedure: DPC with MTA in AGEII

DPC in AGE II with BD

EXPERIMENTAL

DPC using BD in Age group II i.e. 41-60years

Procedure: DPC with BD in AGEII

Interventions

DPC using MTA in 18-40 years

DPC in AGE I with MTA

DPC using BD in 18-40 years

DPC in AGE I with BD

DPC using MTA in 41-60Years

DPC in AGE II with MTA

DPC using BD in 41-60Years

DPC in AGE II with BD

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy patients (ASA I and ASA II).
  • Patients falling in the age group of 18-60 years.
  • Restorable permanent mandibular posterior teeth.
  • Extremely deep caries penetrating the entire thickness of dentine and exhibiting signs and symptoms of reversible pulpitis.
  • Teeth responding positively to cold test and electric pulp testing with no tenderness on percussion.

You may not qualify if:

  • Primary teeth.
  • Traumatic or mechanical exposure.
  • No pulp exposure after caries excavation.
  • Hemostasis not achieved within 10 mins.
  • Teeth with irreversible pulpitis.
  • Presence of periapical lesion or evidence of internal or external resorption, calcified canals, as assessed by radiographic examination.
  • Patients with periodontal disease, swelling and sinus tract.
  • Immunocompromised or pregnant patients, patients with any systemic disease, and a positive history of antibiotic use within 1 month and analgesic use within week before the treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIDS

Rohtak, Haryana, 124001, India

Location

MeSH Terms

Interventions

Pemetrexed

Intervention Hierarchy (Ancestors)

GuanineHypoxanthinesPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsGlutamatesAmino Acids, AcidicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, Dicarboxylic

Study Officials

  • Sanjay Tewari

    pgids rohtak

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The patients and the outcome assessors will be blinded to the allocation groups (double-blinding). But the operator (Principal investigator) will not be blinded due to the nature of the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2024

First Posted

February 2, 2024

Study Start

June 1, 2022

Primary Completion

March 30, 2023

Study Completion

March 30, 2024

Last Updated

February 2, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations